Optieum Biotechnologies Inc.

📍 Toon-shi, Japan🗓 Founded 2020👥 10 employees💰 Last funded 2020
Biotechnology Research
LinkedIn
We are driving the evolution of next-generation CAR-T cell therapy with precision-engineered CAR constructs. Our CAR discovery engine focuses on optimizing the binding domain of CAR to enhance immune cell function, delivering robust therapeutic efficacy. Optieum is pushing the boundaries of solid tumor treatment powered by next-generation CAR constructs.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Japan
1
Frequently asked questions
Who invested in Optieum Biotechnologies Inc.?
Optieum Biotechnologies Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Optieum Biotechnologies Inc. last raise funding?
The most recent investment in Optieum Biotechnologies Inc. recorded on gritt.io was in 2020.
When was Optieum Biotechnologies Inc. founded?
Optieum Biotechnologies Inc. was founded in 2020.
What industry is Optieum Biotechnologies Inc. in?
Optieum Biotechnologies Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Optieum Biotechnologies Inc. based?
Optieum Biotechnologies Inc. is headquartered in Toon-shi, Japan.